...
首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >Type II p21-activated kinases (PAKs) are regulated by an autoinhibitory pseudosubstrate
【24h】

Type II p21-activated kinases (PAKs) are regulated by an autoinhibitory pseudosubstrate

机译:II型p21活化激酶(PAK)受自动抑制伪底物调控

获取原文
获取原文并翻译 | 示例
           

摘要

The type II p21-activated kinases (PAKs) are key effectors of RHO-family GTPases involved in cell motility, survival, and proliferation. Using a structure-guided approach, we discovered that type II PAKs are regulated by an N-terminal autoinhibitory pseudosubstrate motif centered on a critical proline residue, and that this regulation occurs independently of activation loop phosphoryla-tion. We determined six X-ray crystal structures of either full-length PAK4 or its catalytic domain, that demonstrate the molecular basis for pseudosubstrate binding to the active state with phosphorylated activation loop. We show that full-length PAK4 is constitutively autoinhibited, but mutation of the pseudosubstrate releases this inhibition and causes increased phosphor-ylation of the apoptotic regulation protein Bcl-2/Bcl-X_L antagonist causing cell death and cellular morphological changes. We also find that PAK6 is regulated by the pseudosubstrate region, indicating a common type II PAK autoregulatory mechanism. Finally, we find Src SH3, but not p-PIX SH3, can activate PAK4. We provide a unique understanding for type II PAK regulation.
机译:II型p21活化激酶(PAK)是RHO家族GTPases参与细胞运动,存活和增殖的关键效应子。使用结构指导的方法,我们发现II型PAKs受以关键脯氨酸残基为中心的N末端自抑制伪底物基序调控,并且这种调控独立于活化环磷酸化而发生。我们确定了全长PAK4或其催化结构域的六个X射线晶体结构,这些结构证明了伪底物与具有磷酸化激活环的活性态结合的分子基础。我们显示全长PAK4是组成性自抑制的,但假底物的突变释放了这种抑制作用,并引起凋亡调节蛋白Bcl-2 / Bcl-X_L拮抗剂的磷酸化增加,从而导致细胞死亡和细胞形态变化。我们还发现,PAK6受伪底物区域调节,表明一种常见的II型PAK自调节机制。最后,我们发现Src SH3可以激活PAK4,但p-PIX SH3不能。我们对II类PAK法规提供了独特的理解。

著录项

  • 来源
  • 作者单位

    Departments of Pharmacology, Yale University School of Medicine, New Haven, CT 06520;

    Departments of Pharmacology, Yale University School of Medicine, New Haven, CT 06520,Departments of Genetics, Yale University School of Medicine, New Haven, CT 06520;

    Departments of Pharmacology, Yale University School of Medicine, New Haven, CT 06520;

    Departments of Pharmacology, Yale University School of Medicine, New Haven, CT 06520;

    Departments of Pharmacology, Yale University School of Medicine, New Haven, CT 06520,College of Life Science and Technology, Guangxi University, Nanning, Guangxi 530004, China;

    Departments of Pharmacology, Yale University School of Medicine, New Haven, CT 06520;

    Departments of Pathology, Yale University School of Medicine, New Haven, CT 06520;

    Departments of Dermatology, Yale University School of Medicine, New Haven, CT 06520;

    Departments of Pharmacology, Yale University School of Medicine, New Haven, CT 06520,Departments of Yale Cancer Center, Yale University School of Medicine, New Haven, CT 06520;

    Departments of Pharmacology, Yale University School of Medicine, New Haven, CT 06520 ,Departments of Yale Cancer Center, Yale University School of Medicine, New Haven, CT 06520;

    Departments of Pharmacology, Yale University School of Medicine, New Haven, CT 06520 ,Departments of Yale Cancer Center, Yale University School of Medicine, New Haven, CT 06520;

  • 收录信息 美国《科学引文索引》(SCI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    autoregulation; protein kinase; RHO GTPase effector; signaling;

    机译:自动调节蛋白激酶RHO GTPase效应子;发信号;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号